Seasoned investor and operating executive focused on growth-stage technology and financial services businesses. Michael Alfred combines operational leadership with transaction experience across growth equity, M&A and strategic finance, often working with founder-led teams to scale revenue and margins. Prior roles span corporate strategy, buyout and portfolio company management; holds degrees in business and finance.
Seasoned investor and operating executive focused on growth-stage technology and financial services businesses. Michael Alfred combines operational leadership with transaction experience across growth equity, M&A and strategic finance, often working with founder-led teams to scale revenue and margins. Prior roles span corporate strategy, buyout and portfolio company management; holds degrees in business and finance.
Combines operational rigor with growth-equity discipline to back founder-led technology and financial-services companies. Prefers revenue-stage opportunities where strategic capital, M&A experience and hands-on operating support can accelerate scale and margin expansion. Allocates capital with concentrated, conviction-weighted positions and structured governance to protect downside while funding aggressive top-line investments. Maintains a 3–7 year horizon for value realization, prioritizes repeatable unit economics, customer retention, and capital-efficient growth, and emphasizes measurable KPIs, scenario-based stress testing, and collaborative governance.
Combines operational rigor with growth-equity discipline to back founder-led technology and financial-services companies. Prefers revenue-stage opportunities where strategic capital, M&A experience and hands-on operating support can accelerate scale and margin expansion. Allocates capital with concentrated, conviction-weighted positions and structured governance to protect downside while funding aggressive top-line investments. Maintains a 3–7 year horizon for value realization, prioritizes repeatable unit economics, customer retention, and capital-efficient growth, and emphasizes measurable KPIs, scenario-based stress testing, and collaborative governance.
| Trades 53 | Longs Won 29/53 54% | Profit Factor 4.08 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.49M |
| Average Win $1.61M | Best Trade (Sep 08) $22.96M | Sharpe Ratio -11.25 |
| Average Loss -$477,581.3 | Worst Trade (Aug 31) -$8.63M | Z-Score -1.05 (70.84%) |
| Commissions $0 | Avg. Trade Length 5m 1w 6d | Expectancy $665,394.99 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.18% | 1.9% | 15.39% |
| Consecutive Losing Trades | 344 | 310 | 275 | 241 | 207 | 172 | 138 | 103 | 69 | 34 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ASST Strive, Inc. | 560,000 | $5.61M | $15.38M | - | $9.77M | 174.04% | +1.176% |
BBBY Bed Bath & Beyond Inc. | 100,000 | $579,000 | $395,000 | - | -$184,000 | -31.78% | +1.542% |
BKKT Bakkt Holdings, Inc. | 905,000 | $8.51M | $7.68M | - | -$824,750 | -9.69% | +1.921% |
BMNR Bitmine Immersion Technologies, Inc. | 100,000 | $1.93M | $2.51M | - | $581,260 | 30.18% | +0.421% |
CELH Celsius Holdings Inc. | 10,000 | $292,800 | $297,800 | - | $5,000 | 1.71% | -2.87% |
CIFR Cipher Mining Inc. | 3.37M | $42.45M | $65.03M | - | $22.58M | 53.18% | +8.709% |
CP Canadian Pacific Kansas City Limited | 2,000 | $147,260 | $183,210 | - | $35,950 | 24.41% | +0.005% |
ENHA Enhanced Group Inc. | 36,000 | $103,320 | $55,980 | - | -$47,340 | -45.82% | -1.582% |
ETHA iShares Ethereum Trust | 560,000 | $10.07M | $10.55M | - | $476,420 | 4.73% | +1.701% |
IREN IREN Limited | 750,461 | $35.22M | $36.22M | - | $1.01M | 2.86% | +8.035% |
NVO Novo Nordisk A/S Sponsored ADR | 201,000 | $10.19M | $9.13M | - | -$1.06M | -10.36% | -2.479% |
OPEN Opendoor Technologies Inc. | 4.74M | $20.96M | $14.73M | - | -$6.24M | -29.75% | -1.27% |
PEP PepsiCo, Inc. | 1,000 | $143,520 | $138,290 | - | -$5,230 | -3.64% | +0.48% |
REGN Regeneron Pharmaceuticals, Inc. | 500 | $281,135 | $407,335 | - | $126,200 | 44.89% | -1.577% |
SLNH Soluna Holdings Inc. | 750,882 | $1.21M | $976,146.6 | - | -$232,773.42 | -19.25% | +8.333% |
STZ Constellation Brands, Inc. | 1,000 | $137,960 | $121,790 | - | -$16,170 | -11.72% | -4.985% |
TGT Target Corporation | 1,000 | $97,750 | $162,975 | - | $65,225 | 66.73% | -0.891% |
WYNN Wynn Resorts, Limited | 5,000 | $485,450 | $461,031.5 | - | -$24,418.5 | -5.03% | +0.728% |